Allogene Therapeutics, Inc. 13G Filing Shows FMR LLC Holds 17.085% Stake In Co
Portfolio Pulse from Happy Mohamed
FMR LLC has reported a 17.085% stake in Allogene Therapeutics, Inc. according to a 13G filing with the SEC.
July 10, 2023 | 2:25 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
FMR LLC's 13G filing reveals a 17.085% stake in Allogene Therapeutics, Inc. This could potentially influence the stock's performance.
FMR LLC's significant stake in Allogene Therapeutics, Inc. could potentially influence the company's stock performance. However, the exact impact will depend on various factors including market conditions and investor sentiment towards FMR LLC's investment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100